NFE2L2 and neoplasm: Although NRF2 is a well-characterised cytoprotective factor in normal cells, its sustained activation protects tumour cells against chemo- and radiation therapies and promotes metabolic switches that support cell proliferation and tumour growth [3,4,5,6,7].